Abstract: An information processing center that is communicable with a vehicle includes: a reception unit configured to receive a state quantity of a battery mounted in the vehicle such as an internal resistance value, a temperature, and a state of charge of the battery from the vehicle; a derivation unit configured to derive estimated resistance information which is data obtained by estimating correspondence between the temperature and the internal resistance value of the battery based on the state quantity received by the reception unit when the internal resistance value received by the reception unit is equal to or greater than a predetermined resistance value; and a determination unit configured to determine whether an abnormality has occurred in the battery based on the estimated resistance information and deterioration resistance information which is data indicating the correspondence between the temperature and the internal resistance value in a deteriorated state of the battery.

Abstract: A battery diagnosis device includes: one or more sensors which measure at least one of a current value, a voltage value, and a temperature value of a battery; a first determination unit which acquires, from the sensor, at least one of measured values of the current value, the voltage value, and the temperature value of the battery, and determines a state of the battery by using a first method, based on the acquired measured values; a second determination unit which acquires, from the sensor, at least one of measured values of the current value, the voltage value, and the temperature value of the battery, and determines the state of the battery by using a second method different from the first method, based on the acquired measured values; and a diagnosis unit which diagnoses the battery, based on determination results of the first determination unit and the second determination unit.

Abstract: A battery control device that: computes a potential power output capable of being output by a second battery capable of supplying power to onboard equipment of a vehicle in place of a first battery for supplying power to the onboard equipment, measures a temperature of the second battery, and determines whether or not the second battery is a suitable substitute for the first battery depending on whether or not the measured temperature is a preset set temperature or above.

Abstract: A vehicle battery controller includes a sensor configured to acquire information on a subordinate battery configured to back up a main battery during autonomous driving, a DDC provided between the main battery and the subordinate battery, a switching circuit configured to switch a connection state of the subordinate battery between a connection state for manual driving and a connection state for the autonomous driving, and an electronic control unit configured to control charging and discharging of the subordinate battery by controlling the DDC and the switching circuit based on the information acquired by the sensor. The electronic control unit permits the autonomous driving when determination is made, through first battery control, that the subordinate battery can output backup power. The electronic control unit determines whether the subordinate battery can output the backup power by executing second battery control having higher accuracy than that of the first battery control.

Abstract: A vehicle control device includes a connection switching unit configured to switch the connection state to a state in which a second battery is solely connected to a first load when a voltage of a first battery is determined to be equal to or smaller than a first threshold value in a state in which the first and second batteries are connected to the first load, and after a first time has elapsed from switching to the second state, continue the state while the state of charge of the second battery is equal to or greater than a second threshold value, and switch the connection state to a state in which neither the first battery nor the second battery is connected to the first load when the state of charge of the second battery is smaller than the second threshold value.

Abstract: A battery diagnosis device includes: one or more sensors which measure at least one of a current value, a voltage value, and a temperature value of a battery; a first determination unit which acquires, from the sensor, at least one of measured values of the current value, the voltage value, and the temperature value of the battery, and determines a state of the battery by using a first method, based on the acquired measured values; a second determination unit which acquires, from the sensor, at least one of measured values of the current value, the voltage value, and the temperature value of the battery, and determines the state of the battery by using a second method different from the first method, based on the acquired measured values; and a diagnosis unit which diagnoses the battery, based on determination results of the first determination unit and the second determination unit.

Abstract: A vehicle control device includes a connection switching unit configured to switch the connection state to a state in which a second battery is solely connected to a first load when a voltage of a first battery is determined to be equal to or smaller than a first threshold value in a state in which the first and second batteries are connected to the first load, and after a first time has elapsed from switching to the second state, continue the state while the state of charge of the second battery is equal to or greater than a second threshold value, and switch the connection state to a state in which neither the first battery nor the second battery is connected to the first load when the state of charge of the second battery is smaller than the second threshold value.

Abstract: A battery diagnosis device includes: one or more sensors which measure at least one of a current value, a voltage value, and a temperature value of a battery; a first determination unit which acquires, from the sensor, at least one of measured values of the current value, the voltage value, and the temperature value of the battery, and determines a state of the battery by using a first method, based on the acquired measured values; a second determination unit which acquires, from the sensor, at least one of measured values of the current value, the voltage value, and the temperature value of the battery, and determines the state of the battery by using a second method different from the first method, based on the acquired measured values; and a diagnosis unit which diagnoses the battery, based on determination results of the first determination unit and the second determination unit.

Abstract: A vehicle battery controller includes a sensor configured to acquire information on a subordinate battery configured to back up a main battery during autonomous driving, a DDC provided between the main battery and the subordinate battery, a switching circuit configured to switch a connection state of the subordinate battery between a connection state for manual driving and a connection state for the autonomous driving, and an electronic control unit configured to control charging and discharging of the subordinate battery by controlling the DDC and the switching circuit based on the information acquired by the sensor. The electronic control unit permits the autonomous driving when determination is made, through first battery control, that the subordinate battery can output backup power. The electronic control unit determines whether the subordinate battery can output the backup power by executing second battery control having higher accuracy than that of the first battery control.

Abstract: A battery diagnosis device includes: one or more sensors which measure at least one of a current value, a voltage value, and a temperature value of a battery; a first determination unit which acquires, from the sensor, at least one of measured values of the current value, the voltage value, and the temperature value of the battery, and determines a state of the battery by using a first method, based on the acquired measured values; a second determination unit which acquires, from the sensor, at least one of measured values of the current value, the voltage value, and the temperature value of the battery, and determines the state of the battery by using a second method different from the first method, based on the acquired measured values; and a diagnosis unit which diagnoses the battery, based on determination results of the first determination unit and the second determination unit.

Abstract: Disclosed is a novel aralkyl carboxylic acid compound which has an agonistic activity on GPR-120 and/or GPR-40, particularly GPR-120, and is therefore useful as an appetite regulator, an anti-obesity agent, a therapeutic agent for diabetes, a pancreatic beta differentiating cell growth enhancer, a therapeutic agent for metabolic syndrome, a therapeutic agent for a gastrointestinal disease, a therapeutic agent for a neuropathy, a therapeutic agent for a mental disorder, a therapeutic agent for a pulmonary disease, a therapeutic agent for a pituitary hormone secretion disorder or a lipid flavoring/seasoning agent. The aralkyl carboxylic acid compound is represented by the general formula (I).

Abstract: Disclosed is a novel aralkyl carboxylic acid compound which has an agonistic activity on GPR-120 and/or GPR-40, particularly GPR-120, and is therefore useful as an appetite regulator, an anti-obesity agent, a therapeutic agent for diabetes, a pancreatic beta differentiating cell growth enhancer, a therapeutic agent for metabolic syndrome, a therapeutic agent for a gastrointestinal disease, a therapeutic agent for a neuropathy, a therapeutic agent for a mental disorder, a therapeutic agent for a pulmonary disease, a therapeutic agent for a pituitary hormone secretion disorder or a lipid flavoring/seasoning agent. The aralkyl carboxylic acid compound is represented by the general formula (I).

Abstract: Disclosed are a substance and a pharmaceutical product inhibiting activation of a G protein-coupled receptor.

Abstract: Provided are a prophylactic/therapeutic agent for a stress-induced bowel disease, containing, as an active ingredient, at least one kind selected from the group consisting of histidine, a peptide comprising histidine, a precursor thereof and a pharmacologically acceptable salt thereof, a food/beverage having prophylactic/ameliorating action on the disease, a suppressant of the release of a chemical transmitter during stress induction, and a food/beverage having suppressive action on the release of the transmitter.

Abstract: Each gene in a group comprising many genes is cloned into an expression vector so that its gene product should be expressed as a fusion protein with a protein emitting self-fluorescence to construct a gene expression library. The gene expression library is introduced into cells of two groups to express the fusion proteins in the cells, and only one cell group is stimulated by a drug or the like. Then, cells in which the fusion proteins are localized in the nuclei or their nuclei are isolated from cells of the two groups, respectively. By comparing these cells, genes coding for proteins that are transported into the nuclei specifically in response to a certain stimulus when the stimulus is applied to the cells are retrieved.

Abstract: An isolated polypeptide comprises the amino acid sequence of SEQ ID NO: 11, wherein the expression of said polypeptide is significant lower specifically in human livers with hepatitis compared with that in human health livers. The detection of said polypeptide expression in human liver can be used as a diagnosis for human hepatitis.

Abstract: Bone marrow erythroid progenitor cell(s) differentiation may be induced and anemia may be treated by administering arginine. Arginine is an excellent differentiation inducer, because it has high safety, can be orally administered, and is widely used.

Abstract: The present invention provides methods of screening for enhancers and/or inhibitors of a hematopoietic factor production promoter comprising arginine as an active ingredient. Arginine is an excellent hematopoietic factor production promoter, because it has high safety, can be orally administered, and is widely used.

Abstract: A gene panel comprising a group of genes of which expression levels change in hepatocytes during liver regeneration as compared with those in a normal state is produced by the following steps: (a) the step of measuring expression levels of various genes in hepatocytes of a model animal in a normal state and expression levels of the genes during liver regeneration; (b) the step of comparing the expression levels, respectively; and (c) the step of identifying a group of genes of which expression levels change during liver regeneration.

Abstract: The present invention provides a pharmaceutical agent (e.g., a therapeutic agent) for treatment of mitochondrial disorders, which is highly safe with minimal adverse effects. Thus, the pharmaceutical agent is extremely useful as a medical product for mitochondrial disorders. The present invention also provides a method for preventing, ameliorating and/or therapeutically treating mitochondrial disorders by administering the pharmaceutical agent of the present invention.